LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | CP724714 | 10.0 | uM | LJP5 | 72 | hr | 658 | 3308 | 3846 | 0.8601 | 0.8312 |
Hs 578T | CP466722 | 10.0 | uM | LJP5 | 72 | hr | 658 | 1961 | 3846 | 0.5100 | 0.4089 |
Hs 578T | Crizotinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 867 | 3846 | 0.2256 | 0.0657 |
Hs 578T | Momelotinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 561 | 3846 | 0.1459 | -0.0305 |
Hs 578T | Dasatinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 608 | 3846 | 0.1582 | -0.0156 |
Hs 578T | Dasatinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 436 | 3846 | 0.1134 | -0.0697 |
Hs 578T | Dovitinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 868 | 3846 | 0.2259 | 0.0660 |
Hs 578T | Enzastaurin | 10.0 | uM | LJP5 | 72 | hr | 658 | 3433 | 3846 | 0.8927 | 0.8705 |
Hs 578T | Erlotinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 2420 | 3846 | 0.6294 | 0.5529 |
Hs 578T | Foretinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 431 | 3846 | 0.1122 | -0.0711 |
Hs 578T | R406 | 10.0 | uM | LJP6 | 72 | hr | 658 | 984 | 3846 | 0.2560 | 0.1024 |
Hs 578T | Pictilisib | 10.0 | uM | LJP6 | 72 | hr | 658 | 1333 | 3846 | 0.3468 | 0.2119 |
Hs 578T | Gefitinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 3123 | 3846 | 0.8122 | 0.7734 |
Hs 578T | Geldanamycin | 10.0 | uM | LJP5 | 72 | hr | 658 | 588 | 3846 | 0.1530 | -0.0219 |
Hs 578T | Geldanamycin | 10.0 | uM | LJP6 | 72 | hr | 658 | 425 | 3846 | 0.1105 | -0.0731 |
Hs 578T | GSK1059615 | 10.0 | uM | LJP5 | 72 | hr | 658 | 223 | 3846 | 0.0581 | -0.1364 |
Hs 578T | GSK1059615 | 10.0 | uM | LJP6 | 72 | hr | 658 | 479 | 3846 | 0.1246 | -0.0561 |
Hs 578T | GSK1904529A | 10.0 | uM | LJP6 | 72 | hr | 658 | 3670 | 3846 | 0.9543 | 0.9449 |
Hs 578T | Omipalisib | 10.0 | uM | LJP6 | 72 | hr | 658 | 353 | 3846 | 0.0919 | -0.0956 |
Hs 578T | GSK 690693 | 10.0 | uM | LJP5 | 72 | hr | 658 | 3279 | 3846 | 0.8526 | 0.8221 |
Hs 578T | GW843682X | 10.0 | uM | LJP6 | 72 | hr | 658 | 911 | 3846 | 0.2370 | 0.0794 |
Hs 578T | HG-5-113-01 | 10.0 | uM | LJP5 | 72 | hr | 658 | 581 | 3846 | 0.1512 | -0.0240 |
Hs 578T | HG-5-88-01 | 10.0 | uM | LJP6 | 72 | hr | 658 | 2287 | 3846 | 0.5946 | 0.5109 |
Hs 578T | Imatinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 3447 | 3846 | 0.8962 | 0.8748 |
Hs 578T | JNK-9L | 10.0 | uM | LJP6 | 72 | hr | 658 | 506 | 3846 | 0.1317 | -0.0475 |